Investigating the Effect of Cervical Spondylotic Myelopathy on Patients’ Handwriting

Overview

About this study

The purpose of this study is to determine if there are any changes in handwriting of patients with cervical spondylotic myelopathy, and assess the value of handwriting changes as an early predictor in the disease.

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:      

  1. Confirmed cervical spondylotic myelopathy (CSM) diagnosis
  2. CSM patients undergoing surgical treatment
  3. Patients above the age of 21

Exclusion Criteria:     

  1. Patients under the age of 21
  2. Patients with upper extremity deformities
  3. Patients with any neurological impairments or diseases that could confound variables

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Mohamad Bydon, M.D.

Open for enrollment

Contact information:

Sandy Goncalves M.S.

(507)538-6546

Goncalves.Sandy@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20438431

Mayo Clinic Footer